[go: up one dir, main page]

HUE040099T2 - Eljárás termoregulációs zavar kezelésére paroxetinnel - Google Patents

Eljárás termoregulációs zavar kezelésére paroxetinnel

Info

Publication number
HUE040099T2
HUE040099T2 HUE13190594A HUE13190594A HUE040099T2 HU E040099 T2 HUE040099 T2 HU E040099T2 HU E13190594 A HUE13190594 A HU E13190594A HU E13190594 A HUE13190594 A HU E13190594A HU E040099 T2 HUE040099 T2 HU E040099T2
Authority
HU
Hungary
Prior art keywords
paroxetine
disfunction
treating
treating thermoregulatory
thermoregulatory disfunction
Prior art date
Application number
HUE13190594A
Other languages
English (en)
Inventor
Patricia Allison Tewes Richards
Original Assignee
Sebela International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39030027&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE040099(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sebela International Ltd filed Critical Sebela International Ltd
Publication of HUE040099T2 publication Critical patent/HUE040099T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HUE13190594A 2006-08-04 2007-07-31 Eljárás termoregulációs zavar kezelésére paroxetinnel HUE040099T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/499,586 US20080033050A1 (en) 2006-08-04 2006-08-04 Method of treating thermoregulatory disfunction with paroxetine

Publications (1)

Publication Number Publication Date
HUE040099T2 true HUE040099T2 (hu) 2019-02-28

Family

ID=39030027

Family Applications (2)

Application Number Title Priority Date Filing Date
HUE13190594A HUE040099T2 (hu) 2006-08-04 2007-07-31 Eljárás termoregulációs zavar kezelésére paroxetinnel
HUE07810919A HUE040481T2 (hu) 2006-08-04 2007-07-31 Eljárás hõszabályozás rendellenes mûködésének kezelésére paroxetinnel

Family Applications After (1)

Application Number Title Priority Date Filing Date
HUE07810919A HUE040481T2 (hu) 2006-08-04 2007-07-31 Eljárás hõszabályozás rendellenes mûködésének kezelésére paroxetinnel

Country Status (27)

Country Link
US (7) US20080033050A1 (hu)
EP (2) EP2719385B1 (hu)
JP (2) JP5846717B2 (hu)
KR (3) KR20150132888A (hu)
CN (1) CN101505759A (hu)
AU (1) AU2007282065B2 (hu)
BR (1) BRPI0715087A2 (hu)
CA (1) CA2659577C (hu)
CY (2) CY1120867T1 (hu)
DK (2) DK2719385T3 (hu)
ES (2) ES2698207T3 (hu)
HR (2) HRP20181893T1 (hu)
HU (2) HUE040099T2 (hu)
IL (1) IL196844A (hu)
LT (2) LT2068881T (hu)
ME (1) ME00592B (hu)
MX (1) MX2009001275A (hu)
NO (1) NO343176B1 (hu)
NZ (1) NZ574735A (hu)
PL (2) PL2068881T3 (hu)
PT (2) PT2719385T (hu)
RS (2) RS58046B1 (hu)
RU (1) RU2478379C2 (hu)
SG (1) SG176452A1 (hu)
SI (2) SI2068881T1 (hu)
UA (1) UA96770C2 (hu)
WO (1) WO2008019010A2 (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
US9211290B2 (en) * 2012-12-31 2015-12-15 Noven Therapeutics, Llc Solid dispersions of amorphous paroxetine mesylate
CN107249615B (zh) * 2015-04-07 2021-02-05 株式会社明治 潮热抑制剂
KR102817311B1 (ko) 2016-09-29 2025-06-09 (주)아모레퍼시픽 젖산을 유효성분으로 포함하는 열성홍조 개선용 건강식품 조성물

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
GB8520154D0 (en) * 1985-08-10 1985-09-18 Beecham Group Plc Chemical process
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
GB8714707D0 (en) * 1987-06-23 1987-07-29 Beecham Group Plc Chemical process
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
US5470846A (en) * 1994-01-14 1995-11-28 Sandyk; Reuven Treatment of neurological and mental disorders
JPH0837567A (ja) 1994-07-26 1996-02-06 Olympus Optical Co Ltd 情報記録媒体及び情報再生装置
US5856493A (en) * 1995-02-06 1999-01-05 Smithkline Beecham Corporation Process for making novel form of paroxeting hydrochloride anhydrate
SE9501567D0 (sv) * 1995-04-27 1995-04-27 Astra Ab A new combination
US6548084B2 (en) * 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
JP3882224B2 (ja) * 1996-05-31 2007-02-14 旭硝子株式会社 パロキセチンの製造方法
US6638948B1 (en) 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
US5672612A (en) * 1996-09-09 1997-09-30 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
CA2193939C (en) * 1996-12-24 2002-02-12 K.S. Keshava Murthy Useful form of anhydrous paroxetine hydrochloride
GB9700690D0 (en) * 1997-01-15 1997-03-05 Smithkline Beecham Plc Novel process
GB9710004D0 (en) * 1997-05-17 1997-07-09 Knoll Ag Chemical process
US5910319A (en) * 1997-05-29 1999-06-08 Eli Lilly And Company Fluoxetine enteric pellets and methods for their preparation and use
TR199902929T2 (xx) * 1997-05-29 2000-06-21 Smithkline Beecham Corporation Yeni proses.
SK283394B6 (sk) * 1997-06-10 2003-07-01 Synthon B. V. Zlúčeniny 4-fenylpiperidínu a jej farmaceuticky prijateľné soli, spôsob ich prípravy, liečivo s ich obsahom a ich použitie
US5955475A (en) * 1997-06-30 1999-09-21 Endo Pharmaceuticals Inc. Process for manufacturing paroxetine solid dispersions
SE9900190D0 (sv) * 1999-01-22 1999-01-22 Astra Ab New compounds
SE9702799D0 (sv) * 1997-07-25 1997-07-25 Astra Ab New compounds
US6133277A (en) * 1997-12-05 2000-10-17 Janssen Pharmaceutica N.V. (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
IL138084A0 (en) 1998-03-02 2001-10-31 Lilly Co Eli Fluoxetine hydrochloride for decreasing hot flashes
EA200000946A1 (ru) 1998-03-16 2001-02-26 Смитклайн Бичам Плс Кристаллическая форма пароксетина
US6699882B2 (en) * 1998-03-24 2004-03-02 Smithkline Beecham P.L.C. Paroxetine compositions
US20030028027A1 (en) * 1998-04-09 2003-02-06 Smithkline Beecham Plc Paroxetine maleate
JP3796351B2 (ja) * 1998-04-13 2006-07-12 住友化学株式会社 パロキセチン塩酸塩無水和物の乾燥方法
US6168805B1 (en) * 1998-05-07 2001-01-02 Endo Pharmaceuticals, Inc. Aqueous process for manufacturing paroxetine solid dispersions
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
ES2138937B1 (es) * 1998-07-07 2000-10-01 Medichem Sa Polimorfo de maleato de paroxetina y formulaciones farmaceuticas que lo contienen.
ES2159260B1 (es) * 1999-06-22 2002-05-01 Smithkline Beechan Plc Nueva composicion de metanosulfonato de paroxetina
US6369051B1 (en) * 2000-07-06 2002-04-09 American Home Products Corporation Combinations of SSRI and estrogenic agents
US6660298B1 (en) * 2000-07-27 2003-12-09 Pentech Pharmaceuticals, Inc. Paroxetine tablets and capsules
HUP0303827A2 (hu) 2000-08-28 2004-04-28 Synthon B.V. Paroxetinkészítmények és eljárások ezek előállítására
US6498184B2 (en) * 2000-12-05 2002-12-24 Akzo Nobel N.V. Serotonergic compound for a method of treatment of hot flushes in post-menopausal women
PT1347960E (pt) * 2001-01-04 2005-03-31 Ferrer Int Processo para a preparacao de (+)-trans-4-p-fluorofenil-3-hidroximetil-1-metilpiperidina
DE20100529U1 (de) 2001-01-11 2001-05-10 Synthon Bv Pharmazeutische Tablette umfassend Paroxetinmesylat
NL1017421C2 (nl) * 2001-02-21 2002-01-15 Synthon Bv Werkwijze voor het vervaardigen van paroxetine.
EP1266659A1 (en) 2001-06-11 2002-12-18 Pantarhei Bioscience B.V. Pyridoxal in combination with serotonin re-uptake inhibitor for the treatment of hot flushes
US6956121B2 (en) * 2002-03-01 2005-10-18 Teva Pharmaceutical Industries Ltd. Preparation of paroxetine involving novel intermediates
CN1674907A (zh) * 2002-08-14 2005-09-28 法玛西亚普强责任有限公司 瑞波西汀在治疗热潮红中的用途
US20040152710A1 (en) 2002-10-15 2004-08-05 Deecher Darlene Coleman Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms
ITMI20022344A1 (it) * 2002-11-05 2004-05-06 Biofarm Srl Prodotto in pellicola a rapida dissoluzione in acqua, per il trattamento del latte con batteri e/o enzimi.
TWI267838B (en) * 2003-01-03 2006-12-01 Lite On It Corp Method to detect the type of optical disk
US20050130987A1 (en) 2003-10-14 2005-06-16 Wyeth Methods of treating vasomotor symptoms
CA2574310A1 (en) * 2004-07-22 2006-02-02 Wyeth Method for treating nervous system disorders and conditions
JP2008507552A (ja) * 2004-07-22 2008-03-13 ワイス 神経系障害および状態の治療方法
US20060100263A1 (en) * 2004-11-05 2006-05-11 Anthony Basile Antipyretic compositions and methods
KR100764679B1 (ko) 2005-07-22 2007-10-09 익수제약 주식회사 파록세틴을 함유하는 경피투여용 패취제
SI1933809T1 (sl) * 2005-10-11 2012-08-31 Yissum Res Dev Co Sestavki za mazalno dajanje
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine

Also Published As

Publication number Publication date
CA2659577A1 (en) 2008-02-14
JP5895009B2 (ja) 2016-03-30
WO2008019010A3 (en) 2008-12-24
US20080033050A1 (en) 2008-02-07
RS57980B1 (sr) 2019-01-31
CY1120902T1 (el) 2019-12-11
EP2719385A1 (en) 2014-04-16
LT2719385T (lt) 2018-12-27
US20180036299A1 (en) 2018-02-08
US20170165251A1 (en) 2017-06-15
RU2478379C2 (ru) 2013-04-10
JP5846717B2 (ja) 2016-01-20
US20140249182A1 (en) 2014-09-04
JP2014077023A (ja) 2014-05-01
US20140235674A1 (en) 2014-08-21
US20090275615A1 (en) 2009-11-05
US20200268733A9 (en) 2020-08-27
WO2008019010A2 (en) 2008-02-14
NO343176B1 (no) 2018-11-26
EP2068881B1 (en) 2018-08-22
IL196844A0 (en) 2009-12-24
CA2659577C (en) 2015-11-24
ES2699298T3 (es) 2019-02-08
DK2068881T3 (en) 2018-12-10
DK2719385T3 (en) 2018-12-10
SI2719385T1 (sl) 2019-01-31
RU2009107739A (ru) 2010-09-10
AU2007282065A1 (en) 2008-02-14
JP2009545593A (ja) 2009-12-24
ME00592A (en) 2011-12-20
MX2009001275A (es) 2009-04-16
ES2698207T3 (es) 2019-02-01
EP2068881A2 (en) 2009-06-17
US8859576B2 (en) 2014-10-14
NZ574735A (en) 2011-03-31
HRP20181925T1 (hr) 2019-01-11
AU2007282065B2 (en) 2013-05-09
CY1120867T1 (el) 2019-12-11
PL2068881T3 (pl) 2019-04-30
US8946251B2 (en) 2015-02-03
PL2719385T3 (pl) 2019-06-28
BRPI0715087A2 (pt) 2015-02-10
US8658663B2 (en) 2014-02-25
KR20090040453A (ko) 2009-04-24
PT2719385T (pt) 2018-12-04
KR20150132888A (ko) 2015-11-26
US20150335631A1 (en) 2015-11-26
NO20090639L (no) 2009-02-25
KR20140098865A (ko) 2014-08-08
ME00592B (me) 2011-12-20
EP2719385B1 (en) 2018-08-29
SI2068881T1 (sl) 2019-01-31
RS58046B1 (sr) 2019-02-28
EP2068881A4 (en) 2009-09-30
UA96770C2 (uk) 2011-12-12
LT2068881T (lt) 2018-12-10
HUE040481T2 (hu) 2019-03-28
CN101505759A (zh) 2009-08-12
US9393237B2 (en) 2016-07-19
PT2068881T (pt) 2018-11-29
IL196844A (en) 2015-11-30
HRP20181893T1 (hr) 2019-01-11
SG176452A1 (en) 2011-12-29

Similar Documents

Publication Publication Date Title
EP2032131A4 (en) Methods of Treatment
ZA200905236B (en) Knitting loom and method of use
GB0605360D0 (en) Method of manufacture
GB0610746D0 (en) Method of treatment
DE602006018715D1 (de) Entzerrerschaltung und Methode
ATE465229T1 (de) Textilbehandlungsverfahren und zusammensetzung
ZA200908708B (en) Heater and method of operation
BRPI0910598A2 (pt) refratário contendo zircônia-carbono e método de produção do mesmo
GB2462704B (en) A single crystal component and a method of heat treating a single crystal component
HRP20181925T1 (hr) Metoda za liječenje termoregulatorne disfunkcije paroksetinom
ZA200901452B (en) Treatment of vertigo with acetyl-L-leucine
EP2086560A4 (en) METHODS OF TREATING EPIPHORA
GB0601950D0 (en) Compositions and methods of treating diabetes
EP2132251A4 (en) COMPOSITION AND METHOD
IL202002A0 (en) Method of treating diabetes
EP2164494A4 (en) Methods of Treatment
EP2058409A4 (en) HEAT TREATMENT PROCESS
EP1993564A4 (en) METHOD AND COMPOSITION FOR TREATING ALLERGIC DISEASES
HK1131909A (en) Method of treating thermoregulatory disfunction with paroxetine
ZA201007680B (en) Method of treating metalliferrous materials
PL1842931T3 (pl) Sposób obróbki cieplnej
EP2203432A4 (en) PROCESSING METHOD
EP2097552A4 (en) METHOD OF MANUFACTURING USING THE THERMOFORMING
GB0624439D0 (en) Technique for treatment of gall-and kidney-stones
GB0618227D0 (en) Novel method of treatment